<p>Percentages of CD44+/ALDH+ cells over 3 days, for A. UM-SCC-1 and B. UM-SCC-47, after 4 Gy X-ray irradiation, showing changes in the proportion of the putative CSC phenotype at each time point.</p
<p>After 3 passages, CD45<sup>−</sup>/Ter119<sup>−</sup> cells were stained with the following surfa...
<p>Flow cytometry dot plots with CD44-Alexa Fluor® 488 signal on the x-axis and SSEA4-Alexa Fluor® 6...
<p>CD44 positive BMSCs were 98.12, 98.85, 93.32, and 94.32%, and CD34 positive cells were 3.25, 2.37...
<p>A. Density plots from flow cytometry analysis of baseline proportions of cell phenotypes by CD44/...
<p>Proportions of CD44+/ALDH+ cells in surviving populations of each generation of A. UM-SCC-1 and B...
<p>PC-3 and DU145 cells were cultivated in 1% O<sub>2</sub> and 20% O<sub>2</sub> coditions for 48 h...
<p>Flow cytometry analysis of CD44/CD24 expression of A) Top left: suspension of MDA-MB-231 treated ...
<p>Data presented as mean percentage of immunopositive cells from four different donors at early (P5...
Randombred Control Line 2 (RBC2) and modern commercial (NC) line satellite cells were incubated at 3...
<p><i>A</i>. Flow cytometric analysis of the CD133+/EpCAM+ fraction in xenograft tumors generated by...
<p>A significant number of ASCs at day 0 are clearly positive for mesenchymal markers, including CD2...
<p>A. Flow cytometry analysis for the expression of CD24 and CD44 in treated cells. B. Real time PCR...
<p>Light grey trace is isotype control, black trace is anti-CD44. (C) Non reduced SDS-PAGE gel showi...
<p>Cells were cultured for 3–4 passages, harvested, and analyzed by a flow cytometry system. The y-a...
<p>The cells were positive for CD105 (97.3%) and CD44 (99%), but negative for CD34 (2.8%), CD31 (2.1...
<p>After 3 passages, CD45<sup>−</sup>/Ter119<sup>−</sup> cells were stained with the following surfa...
<p>Flow cytometry dot plots with CD44-Alexa Fluor® 488 signal on the x-axis and SSEA4-Alexa Fluor® 6...
<p>CD44 positive BMSCs were 98.12, 98.85, 93.32, and 94.32%, and CD34 positive cells were 3.25, 2.37...
<p>A. Density plots from flow cytometry analysis of baseline proportions of cell phenotypes by CD44/...
<p>Proportions of CD44+/ALDH+ cells in surviving populations of each generation of A. UM-SCC-1 and B...
<p>PC-3 and DU145 cells were cultivated in 1% O<sub>2</sub> and 20% O<sub>2</sub> coditions for 48 h...
<p>Flow cytometry analysis of CD44/CD24 expression of A) Top left: suspension of MDA-MB-231 treated ...
<p>Data presented as mean percentage of immunopositive cells from four different donors at early (P5...
Randombred Control Line 2 (RBC2) and modern commercial (NC) line satellite cells were incubated at 3...
<p><i>A</i>. Flow cytometric analysis of the CD133+/EpCAM+ fraction in xenograft tumors generated by...
<p>A significant number of ASCs at day 0 are clearly positive for mesenchymal markers, including CD2...
<p>A. Flow cytometry analysis for the expression of CD24 and CD44 in treated cells. B. Real time PCR...
<p>Light grey trace is isotype control, black trace is anti-CD44. (C) Non reduced SDS-PAGE gel showi...
<p>Cells were cultured for 3–4 passages, harvested, and analyzed by a flow cytometry system. The y-a...
<p>The cells were positive for CD105 (97.3%) and CD44 (99%), but negative for CD34 (2.8%), CD31 (2.1...
<p>After 3 passages, CD45<sup>−</sup>/Ter119<sup>−</sup> cells were stained with the following surfa...
<p>Flow cytometry dot plots with CD44-Alexa Fluor® 488 signal on the x-axis and SSEA4-Alexa Fluor® 6...
<p>CD44 positive BMSCs were 98.12, 98.85, 93.32, and 94.32%, and CD34 positive cells were 3.25, 2.37...